treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine , doxorubicin , and cyclophosphamide versus concurrent etoposide , vincristine , doxorubicin , and cyclophosphamide and chest radiotherapy : a southwest oncology group study .
C0280673
cisplatin
C0042679
vincristine